Related Experiment Video
Updated: Aug 26, 2026

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
Distinct Filament Conformation for Receptor-Bound Amyloid-β from Alzheimer's Disease Brain
Mikhail A Kostylev1, Carmen Butan1, Graham P Roseman1
1Departments of Neuroscience, Yale School of Medicine, New Haven, CT, USA.
Abstract:
Alzheimer's disease is triggered by amyloid-β, with symptoms linked to synapse loss. Oligomeric amyloid-β, rather than monomeric or fibrillar amyloid-β, has been proposed to be the proximate mechanistic cause, but the relevant molecular characteristics have remained unclear. To define the biologically relevant species, we isolated a receptor-bound amyloid-β pool from Alzheimer's disease brain by release with a receptor antagonist and purification to homogeneity. This discrete receptor-bound amyloid-β pool is ten times more abundant than free unbound amyloid-β and is comprised of 65 nm long filaments. The tips of these short filaments bind to prion protein and drive synapse loss from human neurons. Cryo-electron microscopy shows that the receptor-bound amyloid-β consists of two symmetric S-shaped amyloid-β monomers per filament rung. The overall structure is similar to much longer plaque-associated amyloid-β filaments from the same brain and fails to reveal an unrelated "oligomeric" conformation. Nonetheless, the receptor-bound amyloid-β can be distinguished from plaque filaments by the tilt angle of repeating amyloid-β subunits within each filament rung, by amino terminal conformation, by length and by amyloid seeding properties. Characterizing receptor-bound amyloid-β provides insight into neuronal dysfunction separate from plaque aggregation.
More Related Videos
09:52Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System
Published on: December 28, 2017
09:00Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain
Published on: April 28, 2022
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology
Alzheimer Disease l: Introduction